Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Front Endocrinol (Lausanne) ; 15: 1343759, 2024.
Article in English | MEDLINE | ID: mdl-38752176

ABSTRACT

Syndromic autism spectrum conditions (ASC), such as Klinefelter syndrome, also manifest hypogonadism. Compared to the popular Extreme Male Brain theory, the Enhanced Perceptual Functioning model explains the connection between ASC, savant traits, and giftedness more seamlessly, and their co-emergence with atypical sexual differentiation. Overexcitability of primary sensory inputs generates a relative enhancement of local to global processing of stimuli, hindering the abstraction of communication signals, in contrast to the extraordinary local information processing skills in some individuals. Weaker inhibitory function through gamma-aminobutyric acid type A (GABAA) receptors and the atypicality of synapse formation lead to this difference, and the formation of unique neural circuits that process external information. Additionally, deficiency in monitoring inner sensory information leads to alexithymia (inability to distinguish one's own emotions), which can be caused by hypoactivity of estrogen and oxytocin in the interoceptive neural circuits, comprising the anterior insular and cingulate gyri. These areas are also part of the Salience Network, which switches between the Central Executive Network for external tasks and the Default Mode Network for self-referential mind wandering. Exploring the possibility that estrogen deficiency since early development interrupts GABA shift, causing sensory processing atypicality, it helps to evaluate the co-occurrence of ASC with attention deficit hyperactivity disorder, dyslexia, and schizophrenia based on phenotypic and physiological bases. It also provides clues for understanding the common underpinnings of these neurodevelopmental disorders and gifted populations.


Subject(s)
Androgens , Autism Spectrum Disorder , Estrogens , Humans , Androgens/deficiency , Androgens/metabolism , Estrogens/metabolism , Estrogens/deficiency , Autism Spectrum Disorder/metabolism , Autism Spectrum Disorder/physiopathology , Male , Sex Differentiation/physiology , Klinefelter Syndrome/physiopathology , Klinefelter Syndrome/metabolism , Perception/physiology , Brain/metabolism
2.
Neuro Endocrinol Lett ; 27(4): 439-44, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16891992

ABSTRACT

OBJECTIVES: Although impulsivity has been associated with androgens (e.g., testosterone), little is known regarding the relationship between testosterone levels and impulsivity in intertemporal choice (delay discounting). This study was aimed to examine the relationship between delay discounting of gains and losses and testosterone levels, which is of interest in neuroendocrinology and neuroeconomics. METHODS: We assessed degrees to which delayed monetary gains and losses were discounted (hyperbolic discounting rate) in healty male students (age: 22.4+/-2.67). Participants' salivary testosterone levels were also assessed by utilizing liquid chromatography/mass spectroscopy (LC/MS) method. RESULTS: Non-linear curve fitting analysis showed an inverted-U relationship between delay discounting of gains and salivary testosterone levels; while no relationship between salivary testosterone levels and delay discounting of losses was observed. CONCLUSIONS: The results indicate that (i) testosterone may enhance delay discounting rate of gains in non-impulsive subjects, (ii) testosterone may have an opposite (reducing) effect on delay discounting rate of gains in impulsive subjects, and (iii) testosterone is unrelated to subject's sensitivity to future bad outcomes. Implications for evaluating the effects of testosterone treatment and anti-androgenic therapy on impulsive behavior often observed in psychiatrics (e.g., pathological gambling, credit card debt, substance misuse, and needle-sharing) are discussed.


Subject(s)
Choice Behavior/physiology , Economics , Impulsive Behavior/metabolism , Risk-Taking , Testosterone/metabolism , Adult , Decision Making/physiology , Humans , Impulsive Behavior/psychology , Male , Nonlinear Dynamics , Saliva/metabolism , Surveys and Questionnaires , Time Factors
3.
Rinsho Byori ; 53(5): 388-94, 2005 May.
Article in Japanese | MEDLINE | ID: mdl-15966401

ABSTRACT

PURPOSE: To demonstrate that the salivary testosterone (T) concentration measured by liquid chromatography tandem mass spectrometry (LC-MS/MS) is a sensitive biomarker of serum bioavailable testosterone (bio T) concentration and it's decrease with age. METHOD: Saliva and blood samples were collected from healthy 53 Japanese men (16-66yr) three times a day (9: 00-10: 00, 13: 00-14: 00, 17: 00-18: 00). Salivary T and serum total T levels were compared with serum bio T levels fractionated with concanavaline A. All samples were measured by LC-MS/MS. The stability of salivary T concentrations stored at -70 degrees C for 2 months was also examined. RESULTS: Salivary T levels correlated with bio T(r=0.88, n=158) better than total T did (r=0.71, n=159). The decrease of T concentration with age was observed in saliva of each sampling time. In total T, the decrease with age was weaker and was insignificant in the late afternoon. Salivary T was stable for 2 months at -70 degrees C and a freeze/thaw cycle (difference: average 3.7%, SD=8.4%, n=84). CONCLUSIONS: Salivary T measured by LC-MS/MS is a reliable biomarker of T availability and its decrease with aging.


Subject(s)
Aging/physiology , Biomarkers/analysis , Saliva/chemistry , Testosterone/analysis , Testosterone/blood , Adolescent , Adult , Aged , Biological Availability , Chromatography, Liquid , Humans , Male , Mass Spectrometry , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...